| A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population AC Antoniou, X Wang, ZS Fredericksen, L McGuffog, R Tarrell, ... Nature genetics 42 (10), 885-892, 2010 | 406 | 2010 |
| Genome-wide association analysis identifies three new breast cancer susceptibility loci M Ghoussaini, O Fletcher, K Michailidou, C Turnbull, MK Schmidt, E Dicks, ... Nature genetics 44 (3), 312-318, 2012 | 370 | 2012 |
| A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer CA Haiman, GK Chen, CM Vachon, F Canzian, A Dunning, RC Millikan, ... Nature genetics 43 (12), 1210-1214, 2011 | 353 | 2011 |
| Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ... PLoS genetics 9 (3), e1003212, 2013 | 332 | 2013 |
| Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers JD French, M Ghoussaini, SL Edwards, KB Meyer, K Michailidou, ... The American Journal of Human Genetics 92 (4), 489-503, 2013 | 254 | 2013 |
| A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11 A Siddiq, FJ Couch, GK Chen, S Lindström, D Eccles, RC Millikan, ... Human molecular genetics 21 (24), 5373-5384, 2012 | 218 | 2012 |
| DPYD variants as predictors of 5-fluorouracil toxicity in adjuvant colon cancer treatment (NCCTG N0147) RMGRBD Adam M. Lee, Qian Shi, Emily Pavey, Steven R. Alberts, Daniel J ... Journal of the National Cancer Institute 106 (12), 2014 | 204 | 2014 |
| Common breast cancer susceptibility loci are associated with triple-negative breast cancer KN Stevens, CM Vachon, AM Lee, S Slager, T Lesnick, C Olswold, ... Cancer research 71 (19), 6240-6249, 2011 | 153 | 2011 |
| Methylation of the DPYD promoter: an alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patients HH Ezzeldin, AM Lee, LK Mattison, RB Diasio Clinical cancer research 11 (24), 8699-8705, 2005 | 130 | 2005 |
| Associations of common variants at 1p11. 2 and 14q24. 1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium JD Figueroa, M Garcia-Closas, M Humphreys, R Platte, JL Hopper, ... Human molecular genetics 20 (23), 4693-4706, 2011 | 103 | 2011 |
| A DPYD variant (Y186C) in individuals of african ancestry is associated with reduced DPD enzyme activity SM Offer, AM Lee, LK Mattison, C Fossum, NJ Wegner, RB Diasio Clinical Pharmacology & Therapeutics 94 (1), 158-166, 2013 | 101 | 2013 |
| Dihydropyrimidine dehydrogenase deficiency: impact of pharmacogenetics on 5-fluorouracil therapy. A Lee, H Ezzeldin, J Fourie, R Diasio Clinical advances in hematology & oncology: H&O 2 (8), 527-532, 2004 | 82 | 2004 |
| Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers I Blanco, K Kuchenbaecker, D Cuadras, X Wang, D Barrowdale, ... PloS one 10 (4), e0120020, 2015 | 79 | 2015 |
| Fatty acid binding protein 3 (fabp3) is associated with insulin, lipids and cardiovascular phenotypes of the metabolic syndrome through epigenetic modifications in a Northern … Y Zhang, JW Kent, A Lee, D Cerjak, O Ali, R Diasio, M Olivier, J Blangero, ... BMC medical genomics 6 (1), 1, 2013 | 71 | 2013 |
| MET and EGFR mutations identified in ALK-rearranged pulmonary adenocarcinoma: molecular analysis of 25 ALK-positive cases JM Boland, JS Jang, J Li, AM Lee, JA Wampfler, MR Erickson-Johnson, ... Journal of Thoracic Oncology 8 (5), 574-581, 2013 | 67 | 2013 |
| MET and EGFR mutations identified in ALK-rearranged pulmonary adenocarcinoma: molecular analysis of 25 ALK-positive cases JM Boland, JS Jang, J Li, AM Lee, JA Wampfler, MR Erickson-Johnson, ... Journal of Thoracic Oncology 8 (5), 574-581, 2013 | 67 | 2013 |
| Association between DPYD c. 1129-5923 C> G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance). AM Lee, Q Shi, SR Alberts, DJ Sargent, FA Sinicrope, JL Berenberg, ... Pharmacogenetics and genomics, 2015 | 54 | 2015 |
| Common Oncogene Mutations and Novel SND1-BRAF Transcript Fusion in Lung Adenocarcinoma from Never Smokers JS Jang, A Lee, J Li, H Liyanage, Y Yang, L Guo, YW Asmann, PW Li, ... Scientific reports 5, 2015 | 52 | 2015 |
| Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients E Ziv, E Dean, D Hu, A Martino, D Serie, K Curtin, D Campa, B Aftab, ... Nature communications 6, 2015 | 50 | 2015 |
| Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients E Ziv, E Dean, D Hu, A Martino, D Serie, K Curtin, D Campa, B Aftab, ... Nature communications 6, 2015 | 50 | 2015 |
